During this presentation, Dr. Jim Hendrix will discuss the recent research progress in Down syndrome associated Alzheimer’s disease (DS-AD), including updates on the LIFE-DSR study sponsored by LuMind IDSC and progress in the development of new Alzheimer’s biomarkers and blood tests. The session will also discuss the recent approval of a new drug for Alzheimer’s disease, new drugs in the pipeline, and what this could mean for people with Down syndrome.
Source: James Hendrix PhD, Diane Chan MD, PhD, Li-Huei Tsai Phd, and Massachusetts Down Syndrome Congress